And now Watsonhelper has joined the battle against
Post# of 30028
Posted On: 07/17/2014 8:29:08 AM
And now Watsonhelper has joined the battle against the good "doctor" on YMB. This should be fun.
watsonhelper • 18 minutes ago Flag
6users liked this postsusers disliked this posts0Reply
Manipulation supreme....
Dec 2012: LymPro has completed two Phase 1 clinical studies in over 80 patients, showing 98% sensitivity and 96% specificity for Alzheimer's disease diagnosis. FACT
Apr 2013: Lympro Human clinical studies for LymPro with over 160 patients have been completed to date, showing high sensitivity and specificity for Alzheimer’s disease diagnosis. As high sensitivity rates published, FACT.
Newest data shows the same, look at any research papers out there and tell me otherwise. Don't look at a poster, it's not meant to deliver the same info. Even Gerald indicates it's a BRIDGE! Scientists and investors want to see this bridge and they need to see the incubator process to today so that can validate it's not just an overnight miracle.
Your Bogged down Boggi is citing poster data that is analytical in nature to show a gap for valuation. You want to show improvement in studies, you want to show consistent gains. You want to show the past to present, this is called establishing valuation. I think this person is single-handedly screwing the Internet with misguided info. You don't come out of nowhere and start to point out how rough Lympro "was". Where were you last year, the year before, at any point when people touted the belief that it was a huge success and you could have shut down the propaganda with your facts, but you chose now? The PPS rockets and you're on a constant attack to get the message across that it just isn't that good. Facts are clear, look at data, posters are old and are meant to show progression on purpose. I know, this is my world and my realm. Don't try to sell people a bill of goods you're not educated on. Establish a record, gain trust and respect and then you can post all the garbage you want. Less
watsonhelper • 18 minutes ago Flag
6users liked this postsusers disliked this posts0Reply
Manipulation supreme....
Dec 2012: LymPro has completed two Phase 1 clinical studies in over 80 patients, showing 98% sensitivity and 96% specificity for Alzheimer's disease diagnosis. FACT
Apr 2013: Lympro Human clinical studies for LymPro with over 160 patients have been completed to date, showing high sensitivity and specificity for Alzheimer’s disease diagnosis. As high sensitivity rates published, FACT.
Newest data shows the same, look at any research papers out there and tell me otherwise. Don't look at a poster, it's not meant to deliver the same info. Even Gerald indicates it's a BRIDGE! Scientists and investors want to see this bridge and they need to see the incubator process to today so that can validate it's not just an overnight miracle.
Your Bogged down Boggi is citing poster data that is analytical in nature to show a gap for valuation. You want to show improvement in studies, you want to show consistent gains. You want to show the past to present, this is called establishing valuation. I think this person is single-handedly screwing the Internet with misguided info. You don't come out of nowhere and start to point out how rough Lympro "was". Where were you last year, the year before, at any point when people touted the belief that it was a huge success and you could have shut down the propaganda with your facts, but you chose now? The PPS rockets and you're on a constant attack to get the message across that it just isn't that good. Facts are clear, look at data, posters are old and are meant to show progression on purpose. I know, this is my world and my realm. Don't try to sell people a bill of goods you're not educated on. Establish a record, gain trust and respect and then you can post all the garbage you want. Less
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼